ClinicalTrialsFinder

Respiratory Syncytial Virus (RSV) Clinical Trials in Chuo-ku, Tokyo

1 recruitingChuo-ku, Tokyo, Japan

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.

Respiratory Syncytial Virus (RSV)
Pfizer130 enrolled5 locationsNCT07543380